JENI WARRIOR: Open Payments
NPI 1366782641 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$894 in 47 payments from 11 companies in 2025. Trend: 2023 $366 · 2024 $715 · 2025 $894
Food & beverage: $794Education: $100
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 12 | $210 |
| Astellas Pharma US Inc | 5 | $191 |
| Biogen, Inc. | 8 | $169 |
| MAYNE PHARMA COMMERCIAL LLC | 9 | $78 |
| Exeltis, USA Inc. | 4 | $73 |
| Hologic Sales and Service, LLC | 2 | $44 |
| Organon LLC | 3 | $36 |
| SHIELD THERAPEUTICS INC | 1 | $26 |
| PFIZER INC. | 1 | $24 |
| Dexcom, Inc. | 1 | $24 |
Products named: MYFEMBREE, ZURZUVAE, Veozah, SLYND, NEXPLANON, ACCRUFER, ABRYSVO, Dexcom G6 Transmitter.
Industry payments across AR — which companies pay providers there.
